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Abstract
Background: The jellyfish green fluorescent protein (GFP) can be inserted into the middle of
another protein to produce a functional, fluorescent fusion protein. Finding permissive sites for
insertion, however, can be difficult. Here we describe a transposon-based approach for rapidly
creating libraries of GFP fusion proteins.
Results: We tested our approach on the glutamate receptor subunit, GluR1, and the G protein
subunit, s. All of the in-frame GFP insertions produced a fluorescent protein, consistent with the
idea that GFP will fold and form a fluorophore when inserted into virtually any domain of another
protein. Some of the proteins retained their signaling function, and the random nature of the
transposition process revealed permissive sites for insertion that would not have been predicted
on the basis of structural or functional models of how that protein works.
Conclusion: This technique should greatly speed the discovery of functional fusion proteins,
genetically encodable sensors, and optimized fluorescence resonance energy transfer pairs.
Background
The discovery that the jellyfish green fluorescent protein
(GFP) can form a functional fluorophore without other
gene products or co-factors [1] was rapidly followed by re-
ports that GFP can be used to create fluorescent fusion
proteins [e.g. [2,3]]. For the first time, it became possible
to create a wide variety of genetically encodable fluores-
cent fusion proteins that could be followed in living sys-
t ems  [re viewe d in:[4] ]. Mos t GF P f usio n pr ote ins have
been built by placing GFP at either the N- or C-terminus
of the host protein. This can, however, destroy the func-
tion of some host proteins. The alternative is to insert GFP
into the middle of the host protein [5–8]. Unfortunately,
finding a permissive location for insertion of the GFP can
be problematic and time consuming.
One way of speeding the process is to randomly generate
libraries of GFP fusion proteins and then screen for clones
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Figure 1
Transposition with <EGFP-V> (A) The transposon, <EGFP-V>, is flanked by 19 bp inverted repeats, the MEs. The EGFP
coding region is positioned such that when <EGFP-V> inserts between the codons of a target gene, a fusion protein will be
produced. <EGFP-V> also carriesKanr. There is a stop codon in the 5' end of the Kanr cassette in the same frame as the EGFP
coding sequence, so if the transposon lands in an open reading frame, in the correct orientation and frame, a truncated, EGFP-
tagged, protein will initially be produced. Removal of theKanr cassette by Srf I digestion and re-ligation produces a reading
frame that extends across the entire transposon. (B) The target plasmid, sEE in pcDNA1/Amp, encodes an epitope tagged
version of the G protein subunit s. (C) Transposed plasmids carry Ampr and Kanr. <EGFP-V> insertions within the target gene
produce a PCR product when <EGFP-V> is inserted in the correct orientation, and the size of the PCR product reveals which
<EGFP-V> insertions are in the coding sequence.
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that encode functional, fluorescent proteins. One group
used a combination of nick translation and nuclease S1
treatment to randomly insert GFP into a cAMP-dependent
protein kinase regulatory subunit from Dictyostelium[6]. A
surprisingly large number of the resulting fusion proteins
were fluorescent and retained cAMP binding, demonstrat-
ing that this can be a powerful approach. A weakness of
this strategy, however, is that it can produce deletions in
the host sequence. Another approach is to use the random
behavior of a transposon to insert GFP into many differ-
ent places in a target protein. Two synthetic transposons
have been reported that can produce GFP fusion proteins
[9,10]. The design of these transposons included addi-
tional protein domains or linkers between the GFP and
the target protein, however, and little is known about how
many of the resulting proteins continued to function. We
reasoned that a Tn5 transposon [11,12] could be designed
that would generate GFP fusion proteins with relatively
short linkers (~7 amino acids) between the GFP and the
host protein analogous to GFP fusion proteins that have
already been shown to function [6,8]. To test this ap-
proach, we targeted the G protein subunit s and the
glutamate receptor subunit GluR1.
Results
Changes have been made to the Tn5 transposon, and its
transposase, that in concert produce a hyperactive trans-
poson capable of a 1% insertion frequency in an in vitro
reaction [reviewed in: [12]]. This hyperactive Tn5 transpo-
son is defined as any sequence flanked by the inverted 19
base pair repeats known as mosaic ends (MEs). The re-
combinant  Tn5 transposase binds these ME sequences
and, in the presence of Mg2+, catalyzes the random inser-
tion of the transposon into target DNA in a complex proc-
ess that involves generating a 9 base pair staggered nick in
the target. This staggered nick is subsequently repaired to
produce a 9 base pair duplication of the target sequence
that flanks the inserted transposon. Two possible reading
frames extend through the MEs of the Tn5 transposon.
Our initial GFP transposon, <EGFP-V>, was created by
placing the sequence encoding enhanced green fluores-
cent protein (EGFP) in one of these frames such that if the
transposon landed in another coding sequence, in the cor-
rect orientation and frame, it would produce a GFP fusion
protein (figure 1A). The low probability of transposition
in an in vitro reaction made it necessary to include antibi-
otic resistance, so Kanr was added to the transposon
flanked by Srf I restriction sites that can be used to subse-
quently remove it.
An epitope tagged version of the G-protein subunit s
(sEE) was chosen as the first target (figure 1B). Previous
studies have shown that the N- and C-termini of s are im-
portant for its interactions with receptors, G-protein  and
 subunits, and the plasma membrane [13,14], so placing
GFP within internal regions of s is more likely to gener-
ate a functional, fluorescent subunit [8]. Moreover, the
structure of s has been solved [15], making it possible to
interpret the results in the context of the three-dimension-
al structure. After transposition and transformation, colo-
nies expressing dual antibiotic resistance were screened
with PCR to identify clones in which <EGFP-V> had land-
ed in the correct orientation within the coding region (fig-
ure 1C). Assuming that Tn5 behavior is random, the
probability that <EGFP-V> will land in the sEE coding se-
quence during transposition should be the ratio of the
coding sequence to the size of the total plasmid (18.5%).
However, transpositions that disrupt critical elements of
the plasmid (the plasmid origin or the Ampr gene) should
not be recovered after transformation, so the predicted
probability of observed transpositions within the sEE
coding sequence increases to 23.8%, with half of these
(11.9%) being in the correct orientation. PCR screening of
384 Ampr + Kanr resistant colonies identified 44 clones
with <EGFP-V> insertions within the sEE coding region
in the correct orientation (11.4%).
Each clone containing an in-frame insertion should en-
code a truncated s protein with GFP at the carboxy-termi-
nus due to a stop codon in the Kanr. Thirty-five of the
PCR-positive clones were transiently expressed in HEK
293 cells, and 13 were fluorescent. Sequencing confirmed
that the 13 fluorescent constructs were truncated s-GFP
fusion proteins (with 12 being unique insertions) and
that the remaining 22 <EGFP-V> insertions were out of
frame (figure 2A). The 12 clones encoding unique s-GFP
fusion proteins were digested with Srf I and re-ligated to
create full-length fusion proteins (figure 2B). Transient ex-
pression of each of the 12 s-GFP fusion proteins in HEK
293 cells produced a fluorescent signal. This is surprising
because several insertions appear to be in internal and/or
rigid secondary protein structures (figure 3). It appears
that the folding of GFP to form a fluorophore is thermo-
dynamically favorable at most insertion sites.
To determine what effect the GFP insertions had on s lo-
calization, the full-length fusion proteins were transiently
co-expressed in HEK 293 cells with G protein subunits 1
and 7, which have been shown to mediate signaling be-
tween the -adrenergic receptor and Gs[16]. Amino- and
carboxy-terminus GFP fusions, s-GFP(N) and s-
GFP(C), respectively, were also co-expressed with 1 and
7 for comparison. The end-labeled GFP fusions and two
of the transposon insertions, s-GFP(18–20) and s-
GFP(92–94), showed clear localization to the plasma
membrane (figure 4A). The remaining 10 fusion proteins
displayed a uniform fluorescence signal throughout the
cytoplasm (figure 4B).BMC Neuroscience 2002, 3 http://www.biomedcentral.com/1471-2202/3/7
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The fusion proteins were tested for function by assaying
their abilities to stimulate adenylyl cyclase in response to
receptor stimulation. They were co-expressed with the
luteinizing hormone (LH) receptor in HEK 293 cells and
cAMP accumulation was measured in both the presence
and absence of the LH receptor agonist, human chorionic
gonadotropin (hCG). Basal and stimulated cAMP accu-
mulation in cells expressing s-GFP(18–20), s-GFP(92–
94), s-GFP(N), or s-GFP(C) were higher than in cells ex-
pressing vector alone (figure 5A). However, only in cells
expressing s-GFP(92–94) were these differences statisti-
cally significant (p < 0.05). The basal and stimulated activ-
ities of s-GFP(92–94) were less than those of s,
although these differences were not statistically significant
(p < 0.05). The remaining 10 of the12 fusion proteins ex-
hibited no detectable activity. One possible explanation
for the decreased activities of the s-GFP fusion proteins
relative to sEE would be a decrease in protein expression
level. Cell fractionation and immunoblotting with an
anti-EE monoclonal antibody showed that both s-
GFP(92–94) and s-GFP(18–20) were expressed at lower
levels than sEE, in contrast to s-GFP(N) and s-GFP(C)
(figure 5B).
Interpreting these results in the context of the structure of
s leads to a surprising result. A rational approach to de-
signing a fluorescent, functional s-GFP fusion protein
would have most likely targeted the exposed loops [e.g.
[8]], yet these insertions were not functional. The most
functional protein was produced by the insertion of GFP
into an -helix that one would have avoided (figure 3).
The discovery that all of the in-frame insertions in s pro-
duced truncated fluorescent fusion proteins suggested
that we could identify in frame insertions by transiently
expressing all of the transposed clones and visually screen-
ing them for fluorescence. This alternative screening strat-
egy could be particularly useful for large coding regions
where a PCR-based screen might fail. To reduce the
number of transient transfections required, a second
Figure 2
<EGFP-V> Insertions in sEE. (A) Location of 35 <EGFP-V> insertions in the sEE coding region. The 13 labeled insertions
marked above the coding region are in the correct reading frame and encode fluorescent fusion proteins (12 unique insertions,
1 duplication). The insertions are named for the 3 amino acids of s duplicated during transposition. The 22 unlabeled inser-
tions (18 unique) marked below the coding region are those in which <EGFP-V> landed out-of-frame with respect to sEE.
Redundant insertions are indicated by the number of clones recovered at that site (e.g. 2X, 4X). (B) Srf I digestion of the trans-
posed clone, followed by religation, removes theKanr selection cassette and produces the full-length fusion protein. In the final
fusion protein, the EGFP domain is bordered by amino acid linkers encoded by the Tn5 MEs as well as the 9 bp duplication of
the target sequence that is generated during the transposition process.
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transposon was created with enhanced cyan fluorescent
protein (ECFP). Two separate transpositions with the dif-
ferent colored transposons, followed by co-transfections
in the visual screen (one potential green clone and one
potential cyan clone per well), can identify twice as many
in-frame insertions in a given number of transfections.
This approach could be expanded to encompass many dif-
ferent fluorophores.
In the experiments with s, several clones were recovered
with identical transposon insertions. This is consistent
with previous reports of Tn5 preferentially inserting into
particular locations in the target sequence [17,18]. Since
these "hotspots" could become a limiting factor in the
number of unique insertions recovered within a target se-
quence, the second reading frame through the Tn5 MEs
was used for the ECFP transposon. This doubles the
Figure 3
Model of s-GFP(92–94). The GFP insertions into s can be interpreted in the context of the structures of GFP (PDB file:
1EMA) and s-GTP S (PDB file: 1AZT). In this image, the structure of GFP [42] is green, while the helical domain of the sub-
unit [15] is pink, and the GTPase domain is blue. GTP S is yellow. The GFP insertion s-GFP(92–94) that produced a func-
tional G protein subunit is illustrated by the short linkers (encoded by the Tn5 MEs) between GFP and s (dark blue). The
other sites of <EGFP-V> insertion are shown as green spheres. The numbers on the spheres indicate the second of the three
duplicated residues that flank the transposon insertions (the numbers are based on the long form of s).BMC Neuroscience 2002, 3 http://www.biomedcentral.com/1471-2202/3/7
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number of potentially useful insertion sites within a given
target sequence.
The glutamate receptor subunit GluR1 [19] was used to
test the new transposons and the visual screening process.
Independent transpositions of the GluR1 plasmid were
performed with the EGFP and ECFP transposons (<TgPT-
0> and <TcPT-1>, respectively). In 288 co-transfections,
there were 20 wells with EGFP fluorescence, 21 wells with
ECFP fluorescence, and 2 wells with both EGFP and ECFP
fluorescence. Sequencing revealed 35 unique insertions
(17 <TgPT-0> and 18 <TcPT-1>) and 10 repetitive inser-
tions (figure 6A). The recovery of 45 fluorescent clones
from 576 colonies (7.8%) agrees with the predicted fre-
quency of transpositions resulting in GluR1-EGFP/ECFP
fusions (7.7%), which is consistent with the interpreta-
tion that all in-frame insertions produce a fluorescent pro-
tein. Clones representing unique fluorescent fusion
proteins were digested with Srf I to remove the Kanr selec-
tion cassette and re-ligated to generate full-length GluR1-
EGFP/ECFP fusions. These fusion proteins were screened,
in transiently transfected HEK 293 cells, for glutamate-gat-
ed ion channel function. Of the 29 unique tribrid fusion
constructs tested, all produce detectable fluorescence and
6 were functional (figure 6B).
Discussion
Creating functional, fluorescent fusion proteins involves
finding a permissive site for the insertion of GFP, a process
that in most cases still involves some guesswork. The re-
sults of both the s and GluR1 transpositions illustrate
this point. Based on previous studies with the G protein
subunit q [8] we anticipated that an insertion within an
exterior flexible loop region of s would be most likely to
produce a functional fusion protein. Surprisingly, the s
fusion protein that was the most functional, s-GFP (92–
94), resulted from an insertion into an  helix (figure 3),
while the insertions in exposed loops, s-GFP (67–69)
and s-GFP (188–190), were not functional. Similarly, in
the case of GluR1, one of the insertions that produced a
functional channel, GluR1-GFP(526–528), was within
the hydrophobic region thought to be the first transmem-
brane domain (see Additional File: Figure 7). Additional-
ly, within a given region of GluR1, one insertion will
produce a functional channel while another nearby inser-
tion does not (e.g. the intracellular carboxy-terminus re-
gion or the amino terminus between amino acids 210 and
330). The reasons for these discrepancies are not obvious.
The discovery that GFP will still fold and form a fluoro-
phore when placed virtually anywhere in another coding
region suggests that the limiting step in the process is
whether the target protein it is inserted into folds and
functions correctly. Indeed, GFP fusion constructs have
been used to assay, and improve upon, the folding of a va-
riety of proteins in a bacterial expression system [20]. The
relatively random nature of the transposition events we
recovered in this study suggests that it might be possible
to insert GFP at nearly every position in a given protein,
but there are two potential limits. First, the laws of proba-
bility predict that there will be rapidly diminishing re-
turns in the search for unique Tn5 insertions as one
recovers each additional clone. Second, the behavior of
the Tn5 transposon is not entirely random. Goryshin and
colleagues [18] have shown that there is a weak consensus
site for Tn5 insertion which is consistent with our results.
It appears that the resolution limit will be an insertion
each three amino acids on average in a target protein.
Inserting a reporter domain such as GFP into another pro-
tein always has the potential of perturbing the target and
destroying it's ability to function. In this study 16% of the
tribrid fusion proteins were still functional. One explana-
tion for why GFP can be used for internal insertion is that
the N- and C-termini of GFP exit the structure quite close
to one another and are unlikely to displace the surround-
ing domains of the target protein a great deal. This is anal-
ogous to the use of the bovine pancreatic trypsin inhibitor
for internal insertions [21]. The transposons described
here could potentially be improved upon by optimizing
the length and flexibility of the linkers between the target
Figure 4
Localization of s-GFP Fusion Proteins in Living
Cells. (A) Membrane localization of tribrid fusion, s-
GFP(92–94), in HEK 293 cells ~24 hr after co-transfection
with 1 and 7. Similar localization patterns were observed
when  s-GFP(18–20),  s-GFP(N), or s-GFP(C) fusions
were co-expressed with 1 and 7 (A non-linear representa-
tion of the image brightness was used to illustrate both the
dimly fluorescent cells in the upper right corner and the very
bright ones at the bottom, scale bar = 20 m). (B) The
remaining 10 tribrid fusion proteins were evenly distributed
throughout the cytosol (with little fluorescence in the
nucleus) as seen here in HEK 293 cells transiently expressing
s-GFP(362–364), 1 and 7.BMC Neuroscience 2002, 3 http://www.biomedcentral.com/1471-2202/3/7
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Figure 5
Activity and Expression Levels of s-GFP Fusion Proteins. (A) HEK 293 cells were transfected with 2 g/106 cells of
the indicated s-GFP constructs or vector alone (pcDNA1/Amp) and 0.2 g/106 cells of plasmid encoding the LH receptor.
cAMP accumulation was measured in the presence (dark gray bars) or absence (light gray bars) of hCG, an LH receptor ago-
nist. Cells expressing each of the s-GFP fusion proteins exhibited increased basal and stimulated cAMP accumulation relative
to cells expressing vector alone, but only the increases in cells expressing s-GFP(92–94) were significantly greater (p < .05).
Values represent the mean  S.E. of 5 independent experiments. (B) Immunoblots of the membrane pellets (P) and supernatant
(S) fractions from transiently transfected HEK 293 cells. Expression levels of tribrid fusion proteins s-GFP(18–20) and s-
GFP(92–94), but not of amino- and carboxy-terminus fusions, s-GFP(N) and s-GFP(C), respectively, were decreased in both
fractions relative to that of unlabeled sEE. Similar results were obtained in an additional experiment.BMC Neuroscience 2002, 3 http://www.biomedcentral.com/1471-2202/3/7
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Figure 6
Insertion Sites and Functional Screening of GluR1-GFP Fusion Proteins (A) A model of GluR1 topology showing the
locations of the GFP insertion in 45 fluorescent fusion proteins. In-frame insertions of <TgPT-0> result in a 3 amino acid dupli-
cation (green) flanking the insertion site. In-frame insertions of <TcPT-1> generate only a 2 amino acid duplication (cyan) in the
target because of the different reading frame. The orange amino acids are overlapping insertion sites of the two transposons
(See supplemental diagram for the two reading frames). Multiple clones with identical transpositions are identified as 2x, 3x,
etc. The six insertions resulting in functional, fluorescent GluR1-GFP/CFP tribrid fusion proteins are identified by the dupli-
cated target amino acids (e.g. g209–211, c867–868). This figure was adapted from [43]. (B) AMPA receptor-mediated current
from GluR1-CFP(867–868). (B1) Large whole-cell current elicited by the rapid sustained application of 5 mM glutamate (bar) in
a cell transiently expressing GluR1-CFP(867–868) after reducing desensitization with cyclothiazide (100 M). (B2) Current elic-
ited by 5 mM glutamate in an outside-out patch pulled from a cell transiently expressing GluR1-CFP(867–868). (B3) Current
elicited in the same patch as B3, but in the absence of cyclothiazide. Note the rapid and nearly complete desensitization of the
current. (B4) The trace on the left is an expanded time scale of B3, the trace on the right is from an outside-out patch pulled
from a cell transiently expressing wild-type GluR1 in the presence of 5 mM glutamate without cyclothiazide.BMC Neuroscience 2002, 3 http://www.biomedcentral.com/1471-2202/3/7
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and the GFP. Another potential improvement to the proc-
ess would be to use bacterial expression to screen for
transposon insertions that produce a fluorescent protein.
This could, however, be problematic with proteins from
the mammalian nervous sytem, such as ion channels, that
are difficult to express in bacteria.
The approach described here should speed the discovery
of genetically encodable fluorescent sensors. The pioneer-
ing work of Siegel and Isacoff showed that GFP placed
within a portion of the Shaker K+ channel C-terminus pro-
duced a fluorophore that responded to changes in mem-
brane voltage [5], but they built a number of different
constructs before finding one that worked. Similarly, Ata-
ka and Pieribone created an EGFP-Na+ channel fusion
protein that changes fluorescence in response to mem-
brane depolarizations on a time-scale that would be suff-
icent to image action potentials. This discovery, however,
was the result of designing, building, and testing eight dif-
ferent tribrid fusion proteins [22]. Little is known about
the mechanism whereby changes in channel conforma-
tion are converted to changes in the fluorophore, so it re-
mains to be determined whether GFP can signal
conformational changes in other kinds of proteins. Never-
theless, the use of the transposons described here should
shift the work from building the constructs to devising
high throughput assays for function.
Finally, random GFP tagging will facilitate the creation of
potential fluorescence resonance energy transfer (FRET)
reagents to study protein interactions in living systems. To
date, a few studies have demonstrated the potential power
of GFP-FRET by labeling different proteins [6,23–26] or
by fusing two different fluorophores to the same protein
[27–32]. Creating efficent donor and acceptor fusion pro-
teins is difficult, however, because FRET only occurs when
the two fluorophores are attached to surfaces that are very
close to one another. The approach described here makes
it possible to rapidly generate libraries of potential donor
and acceptor tribrid fusion proteins that can be screened,
in pairwise combinations, for function and FRET signals.
Conclusions
The transposons described here make it possible to rapid-
ly generate large numbers of different GFP fusion pro-
teins. The results show that GFP can be inserted into a
wide variety of other protein domains and it will continue
to fold and form a fluorophore. The rapid and random na-
ture of the transposition process makes it possible to gen-
erate and screen many different fusion constructs to
identify those that continue to function. In the case of the
two proteins tested here, roughly 1 in 6 of the fusion pro-
teins retained their signaling function, and the random
nature of the transposition process revealed permissive
sites for insertion that would not have been predicted on
the basis of structural or functional models of how that
protein works. This simple tool should speed the search
for a wide variety of new biological probes for the study of
nervous system.
Materials and Methods
PCR and standard subcloning procedures were use to cre-
ate the initial transposon, <EGFP-V> (full sequence at:
[http://momotion.med.yale.edu]). The Tn5 MEs were
added to the 5' and 3' ends of an EGFP coding sequence,
with a Srf I restriction site at its 3' end, such that one con-
tinuous reading frame extended through both MEs and
EGFP (figure 2). To add antibiotic selection, the Kanr gene
from pUniV5-His-TOPO™ (Invitrogen, Carlsbad, CA) was
flanked with Srf I sites and inserted into the transposon.
The improved transposons, <TgPT-0> and <TcPT-1>, were
created in the same way as <EGFP-V>, but Asc I sites were
added to facilitate changing the fluorescent protein at a
later date (supplemental material). In addition, the two
different reading frames present in the MEs were used to
create the two different transposons, and ECFP was used
in place of EGFP in <TcPT-1>. A primer complementary to
the19 bp Tn5 ME (5'-CTGTCTCTTATACACATCT-3') was
used to amplify the transposons (1 cycle at 95C for 3:30
min., 24 cycles of 95C for 30 sec 47C for 30 sec 72C for
1 min., 1 cycle at 72C for 5 min.) with Pfu polymerase
(Stratagene, La Jolla, CA). The PCR product was purified
and concentrated with the Geneclean II kit (Bio101 Inc.,
Vista, CA) and eluted in 1X TE buffer. 0.2 fmoles of trans-
poson were incubated with 5.0 L of EZ::TN™ transposase
(Epicentre Technologies) in 25% glycerol at 25C for 30
min.
Molar equivalents of transposon and target plasmid (0.4
fmoles ea.) were incubated in reaction buffer (50 mM
Tris-acetate (pH 7.5), 150 mM potassium acetate, 10 mM
magnesium acetate and 4 mM spermidine) at 37C for 2
hr in a 10 L reaction. Transposition was stopped by add-
ing 1 L of 1% SDS and incubating at 70C for 10 min.
Top 10 F' E. coli (Stratagene) were transformed with 1 L
of the transposition reaction and plated on LB agar with
either ampicillin (100 g/mL) and kanamycin (50 g/
mL) to recover transposed clones, or ampicillin (100 g/
mL) alone to establish the transposition efficiency.
The cDNA encoding the rat s [33], modified to carry the
EE epitope [34], was in pcDNA1/Amp (Invitrogen). GFP
was added to the N- or C-terminus of s to create end-la-
beled constructs for comparison with the transposed GFP
tribrid fusion proteins. The amino-labeled clone, GFP-
[GGGPSGGGGS]-sEE, and carboxy-labeled clone, sEE-
[SGGGGSGQH]-GFP, were generated via overlap exten-
sion [35]. Linker sequences are in brackets. The flip vari-
ant of rat GluR1 was in the CMV expression plasmid pRK5BMC Neuroscience 2002, 3 http://www.biomedcentral.com/1471-2202/3/7
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(a generous gift from Derek Bowie, Emory University, At-
lanta, GA).
PCR screening for <EGFP-V> insertions within the sEE
coding region was performed using a protocol described
by Cease et al. [36] using an upper primer complimentary
to the 5' UTR (5'-GCTCCCGCGGCTCCTGCTCTGCTC-
3'), and a lower primer complimentary to EGFP (5'-
GCCGTCGCCGATGGGGGTGTTCTG-3'. The clones that
produced clear PCR products within the expected size
range were then miniprepped (QIAgen, Germantown,
MD).
Insertion sites were identified for all PCR-positive <EGFP-
V> transposed clones and all fluorescent <TgPT-0>/<TcPT-
1> transposed clones by sequencing out of the transposon
with a primer complimentary to the EGFP/ECFP coding
region (5'-tggccgtttacgtcgccgtcca-3'). Srf I restriction diges-
tion was then used to remove theKanr cassette from the
clones carrying in-frame insertions, thereby creating a se-
quence encoding a full-length fusion protein. After diges-
tion and re-ligation, Top 10 F' E. coli were transformed
with 1 L of the ligation reaction and plated on LB agar
containing ampicillin. The colonies were re-plated the fol-
lowing day on ampicillin and kanamycin to verify loss of
theKanr.
The fusion proteins were transiently expressed in HEK 293
cells [37]. Transfections were done using Lipofectamine
2000 (Gibco BRL). Images were collected from live cells
20–48 hr later on an inverted Zeiss microscope fitted with
computer controlled (IPLabs, Scanalytics) filter wheels
(Ludl Electronics) on the excitation and emission paths.
EGFP was imaged with an FITC filter set, while ECFP was
distinguished from EGFP in co-expression experiments by
changing both the excitation and emission filter sets (Ex-
citers: 440AF21 & 500AF25, Dichroic cat# XF 2063, Emit-
ters 480AF & 545AF35; Omega, Brattleboro, VT).
s-GFP fusion proteins were assayed for the ability to
stimulate adenylyl cyclase in response to luteinizing hor-
mone (LH) receptor stimulation [38]. 106 HEK 293 cells/
60 mm-dish were co-transfected with 2 g of plasmid
DNA encoding the s-GFP fusion protein, and 0.2 g of
plasmid DNA encoding the rat LH receptor in pCIS [39],
using 10 L of Lipofectamine 2000. [3H]-adenine-labeled
cells were assayed for cAMP accumulation after incuba-
tion at 37C for 40 min. in the presence of 1 mM 3-iso-
butyl-1-methylxanthine (IBMX) a phosphodiesterase
inhibitor, and in the presence or absence of 7.5 ng/mL hu-
man chorionic gonadotropin (hCG), as described previ-
ously. Conversion of ATP to cAMP was expressed as:
103  [3H]cAMP/([3H]ATP + [3H]cAMP).
12  106 HEK 293 cells were transfected, using DEAE-dex-
tran [40], with 25 g of plasmid DNA. Forty-eight hours
after transfection, cells were lysed and membrane and su-
pernatant fractions harvested as described previously [8].
10 g of membrane proteins and normalized volumes of
the supernatants were resolved by SDS-polyacrylamide
electrophoresis (10%), transferred to nitrocellulose, and
probed with a monoclonal antibody to the EE epitope
[34]. The antigen-antibody complexes were visualized
with ECL chemiluminescence (Amersham Biosciences,
Piscataway, NJ).
Whole-cell patch clamp recording was used to test the
GluR1 fusion proteins for function in transiently trans-
fected HEK 293 cells as previously described [41]. The ex-
ternal solution was (in mM): 150 NaCl, 3 KCl, 2 CaCl2, 1
MgCl2, 5 glucose, 0.002 glycine and 10 HEPES (pH 7.4).
Patch pipettes were filled with a solution containing (in
mM): 120 CsF, 33 KOH, 2 MgCl2, 1 CaCl2, 0.1 spermine,
10 HEPES, and 11 EGTA (pH 7.4). Cyclothiazide was pre-
pared as a 20 mM stock solution in DMSO and diluted to
100  M in external solution. All chemicals were pur-
chased from Sigma. Drugs were applied with a rapid su-
perfusion system made from a pulled theta capillary. The
open tip responses obtained with this system had 10–
90% rise-times of 150 s to 300 s.
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